HCM
RGEN icon

Highbridge Capital Management’s Repligen RGEN Stock Holding History

Highbridge Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,845
Closed -$531K – 1906
2017
Q3 		$531K Buy
+13,845
New +$580K 0.01% 888
2016
Q4 		– Sell
-6,918
Closed -$209K – 1541
2016
Q3 		$209K Buy
+6,918
New +$209K ﹤0.01% 1166

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Highbridge Capital Management's RGEN Position: Q4 2017 in Review

Highbridge Capital Management sold out of Repligen (RGEN) in Q4 2017, closing a stake of 13,845 shares — an estimated $531K sold.

Highbridge Capital Management first reported a position in RGEN in Q3 2016 and held it in 2 quarters. The position peaked at $531K in Q3 2017. 184 funds tracked by Wall St. Rank hold RGEN as of Q4 2017.

  • Highbridge Capital Management reported no remaining Repligen position as of Q4 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 13,845 Repligen shares in Q4 2017, an estimated $531K.
  • Highbridge Capital Management first reported a position in Repligen in Q3 2016 and held it in 2 quarters.
  • Highbridge Capital Management's Repligen position peaked at $531K in Q3 2017.
  • 184 funds tracked by Wall St. Rank held Repligen as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.